Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Healthcare · Surgical & Medical Instruments & Apparatus

Catheter Precision to acquire Ra Medical Systems, Inc.

Announced Sep 12, 2022 · Pending Sep 23, 2022

Deal value$267MEV $267M
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationAll stock

Transaction

Acquirer
Catheter Precision
Target
Ra Medical Systems, Inc. (RMED)
Buyer type
Strategic
Offer price per share
—
Enterprise value
$267M
Status
Pending Sep 23, 2022

Deal protections

Not yet read from the merger agreement.

Advisors

To the acquirer
Not disclosed
To the target
Ladenburg Thalmann

Sector context · Healthcare

Comparable deals
60 in the prior 24 months
Premium
Sector median 50.0%
EV / Adj. EBITDA
Sector median 17.4x
Break fee
Sector median 3.4%

Timeline

  1. AnnouncedSep 12, 2022
  2. Proxy filedSep 23, 2022
  3. Definitive proxyPending
  4. Shareholder votePending
  5. ClosedPending

Valuation · fairness opinions

Other analysis$0.08$0.12
Discounted cash flow$0.18$0.24
Discounted cash flow$0.09$0.12

Implied value per Ra Medical Systems, Inc. share by analysis · DCF discount rate 23%–27.5%.

Sources
  • 8-K (EX-99.1) · Sep 12, 2022

Adj. EBITDA is operating income + D&A + impairment, restructuring, deal costs and stock compensation, less any large gain on a sale, last twelve months, from the target's filings. Calculated by Castle, so it can differ from a bank's adjusted figure.

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.